ARX aroa biosurgery limited

News: ARX Aroa Biosurgery Says Prelim Unaudited FY22 Product Revenue Of About NZ$39.2 Mln

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    April 26 (Reuters) - Aroa Biosurgery Ltd (ARX) :

    • PRELIMINARY UNAUDITED FY22 FULL YEAR PRODUCT REVENUE OF ABOUT NZ$39.2 MILLION
    • FY22 PRELIMINARY UNAUDITED TOTAL REVENUE ABOUT NZ$39.7 MILLION, UP ABOUT 78%
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
67.0¢
Change
-0.025(3.60%)
Mkt cap ! $231.1M
Open High Low Value Volume
69.5¢ 69.5¢ 66.5¢ $126.1K 187.4K

Buyers (Bids)

No. Vol. Price($)
1 6000 65.5¢
 

Sellers (Offers)

Price($) Vol. No.
68.0¢ 7447 1
View Market Depth
Last trade - 16.10pm 19/09/2025 (20 minute delay) ?
ARX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.